CRP vs ESR: What Your Inflammation Blood Tests Really Mean
When joints hurt, the first blood tests most people get are C-reactive protein (CRP) and the erythrocyte sedimentation rate (ESR, or "sed rate"). Both are called inflammation markers, both are often ordered together, and both can be confusing — especially when one is high and the other is normal, or when you clearly have painful joints and both come back "normal." This page explains what each test actually measures, how the high-sensitivity CRP used for heart risk differs from the standard test, what counts as normal for your age and sex, how rheumatologists use them in disease-activity scores, why they disagree, and why a normal result never rules arthritis out on its own.
Key takeaways
- CRP is a liver protein made in response to IL-6; it rises within hours and falls within days, so it tracks current inflammation closely. Strong
- ESR is an indirect test of how fast red cells settle. It rises mainly with fibrinogen, changes over weeks, and is pushed up by age, female sex, anemia, pregnancy and kidney disease. Strong
- hs-CRP is the same molecule measured more precisely at low levels; cut-offs of <1, 1–3 and >3 mg/L describe cardiovascular risk, not arthritis activity. Strong
- The two tests disagree in roughly 1 in 8 paired results; discordance has recognizable causes such as infection, kidney disease and low albumin. Strong
- Normal results do not rule out arthritis. OA is usually normal, gout is often normal between flares, and a third or more of people with RA can have normal ESR and CRP. Strong
- Obesity, smoking and poor sleep raise CRP; healthier habits are associated with lower levels, but lifestyle change is a complement to — not a replacement for — medical care. Emerging
What CRP and ESR actually measure Strong
Both tests detect the body's acute-phase response — the system-wide change in blood proteins that follows infection, injury or immune activation. They do so in very different ways, which explains most of their differences in practice.12
C-reactive protein (CRP): a direct measurement
CRP is a ring-shaped protein made by the liver. When immune cells release the cytokine interleukin-6 (IL-6) — with help from IL-1 and TNF-alpha — liver cells sharply increase CRP production. CRP binds to damaged cells and microbes and helps flag them for clearance. The test measures the amount of CRP protein in a blood sample directly, in milligrams per litre (mg/L) or per decilitre (mg/dL).1
Mechanism: why CRP moves so fast
CRP's plasma half-life is about 19 hours and stays roughly constant whatever the person's health, so the level in the blood is governed almost entirely by how fast the liver is making it. Production starts within hours of an inflammatory stimulus, levels can rise many hundred-fold and typically peak around two days later, and they fall quickly once the stimulus resolves. That makes CRP a close, near-real-time readout of IL-6 activity.1
Erythrocyte sedimentation rate (ESR): an indirect measurement
The ESR does not measure any single molecule. Anticoagulated blood is placed in a tall, thin tube (the Westergren method) and the laboratory records how many millimetres the red cells fall in one hour (mm/hr). Red cells carry a negative surface charge that keeps them apart; positively charged proteins in plasma — chiefly fibrinogen, with contributions from immunoglobulins — neutralize that charge, so cells stack into "rouleaux" that sink faster.23
Mechanism: why ESR is slower and "noisier"
Fibrinogen and immunoglobulins rise more slowly than CRP and linger for weeks, so ESR lags behind changes in inflammation in both directions. Because the result also depends on the red cells themselves and on other plasma proteins, ESR is affected by things that have nothing to do with inflammation: anemia (fewer cells, faster fall), older age, female sex, pregnancy, kidney disease, high immunoglobulin levels, and unusual red-cell shapes such as sickle cells (which slow it down).34
A clinical review summed it up this way: CRP is generally the more sensitive and responsive indicator of inflammation, and false-positive and false-negative results are more common with ESR — yet ESR still has a role in a few specific settings.4 See the inflammatory markers section of our biomarkers guide and the glossary entries for CRP and ESR.
hs-CRP vs standard CRP Strong
"High-sensitivity CRP" is not a different protein — it is the same CRP measured with an assay that is accurate at very low concentrations (down to a fraction of 1 mg/L). The two tests answer different questions:
- Standard CRP is designed to detect clinically obvious inflammation — infection, active inflammatory arthritis, injury — where levels are often above 10 mg/L and can reach the hundreds.
- hs-CRP is designed to detect the persistent low-grade inflammation linked with atherosclerosis, obesity and insulin resistance, in the range of roughly 0.5–10 mg/L.67
| CRP level | Usual interpretation | Evidence |
|---|---|---|
| < 1 mg/L (hs-CRP) | Lower relative cardiovascular risk | Strong |
| 1–3 mg/L (hs-CRP) | Average relative cardiovascular risk | Strong |
| > 3 mg/L (hs-CRP) | Higher relative cardiovascular risk; the 2019 ACC/AHA guideline treats hs-CRP ≥ 2 mg/L as a "risk-enhancing factor" when deciding on statins8 | Strong |
| > 10 mg/L | Too high to use for heart-risk scoring; suggests an active inflammatory or infectious process that should be looked for, and the test repeated later | Strong |
| Tens to hundreds of mg/L | Typical of significant active inflammation or infection; very high values are more often seen with bacterial infection, but no cut-off is diagnostic | Strong |
The CDC/AHA statement recommends that hs-CRP for cardiovascular risk be measured twice, about two weeks apart, in a person who is metabolically stable and free of obvious infection, and averaged.6 In someone with an inflammatory arthritis, a "high-risk" hs-CRP mainly reflects the arthritis itself — though inflammatory arthritis does independently raise cardiovascular risk, which is worth discussing with your doctor.
Reference ranges & the age-adjusted ESR rule Strong
Every laboratory sets its own reference range, so always compare your result with the range printed on your report. The figures below are typical values for adults.
| Test | Typical "normal" | Notes |
|---|---|---|
| Standard CRP | < 5–10 mg/L (< 0.5–1.0 mg/dL) | Cut-off depends on the lab; many healthy adults are below 3 mg/L |
| hs-CRP | < 1 mg/L low risk; 1–3 average; > 3 higher | Cardiovascular-risk categories, not an arthritis range6 |
| ESR, men | Up to about age ÷ 2 mm/hr | Rule of thumb from Westergren data5 |
| ESR, women | Up to about (age + 10) ÷ 2 mm/hr | Higher in women at every age; higher still in pregnancy5 |
The age-adjusted ESR rule was published in the BMJ in 1983 by Miller, Green and Robinson as a simple way to estimate the upper limit of normal: age divided by 2 for men and age plus 10, divided by 2, for women.5 It is a convenience, not a law — but it shows why a single fixed cut-off can mislabel older adults as "inflamed."
| Age | Men (age ÷ 2) | Women ((age + 10) ÷ 2) |
|---|---|---|
| 30 | 15 mm/hr | 20 mm/hr |
| 50 | 25 mm/hr | 30 mm/hr |
| 70 | 35 mm/hr | 40 mm/hr |
| 80 | 40 mm/hr | 45 mm/hr |
CRP vs ESR: side-by-side comparison
The table below brings together the practical differences clinicians weigh when they order and interpret the two tests.1349
| Feature | CRP (and hs-CRP) | ESR (sed rate) |
|---|---|---|
| What is measured | A specific protein, directly | Speed of red-cell settling — an indirect effect of plasma proteins |
| Main driver | IL-6 signalling to the liver | Fibrinogen and immunoglobulins |
| Rises after a trigger | Within hours; peaks around 2 days | Over days |
| Returns to normal | Within days of the trigger resolving | Over weeks; can lag behind recovery |
| Units | mg/L or mg/dL | mm/hr |
| Affected by age and sex | Slightly | Yes — higher with age and in women |
| Affected by anemia, red-cell shape | No | Yes — anemia raises it; sickle cells and polycythemia lower it |
| Affected by kidney disease, pregnancy | Less so | Yes — both tend to raise it |
| Affected by obesity | Yes — adipose tissue releases IL-6 | Modestly |
| Low-level precision | hs-CRP detects levels below 1 mg/L | Not designed for low-grade inflammation |
| Sample handling | Stable; can be run on stored serum | Must be run within hours; affected by tube tilt and temperature |
| Particular strengths | Tracking acute inflammation and infection; response to treatment | Giant cell arteritis and polymyalgia rheumatica; some chronic bone infections; lupus monitoring |
| Role in RA scoring | DAS28-CRP, SDAI | DAS28-ESR (the original version) |
| As a screening test in people without symptoms | Not useful for arthritis screening | Not useful; unexplained rises are usually transient9 |
Why CRP and ESR can disagree Strong
Because they measure different things on different timescales, CRP and ESR do not always move together. In a study of 1,731 adults at a Texas hospital, results differed substantially (two or more quartiles apart) in 12% of patients — about 1 in 8 — split evenly between "high CRP / low ESR" and "high ESR / low CRP."10 A Boston study using a stricter definition found discordance in about 4% of 2,069 patients and linked a high ESR with low CRP to infection, kidney insufficiency and low albumin.11
High CRP, normal ESR
High ESR, normal CRP
- Inflammation that is resolving — CRP has fallen, ESR still lagging
- Anemia, older age, pregnancy, chronic kidney disease311
- High immunoglobulins (e.g. myeloma, some chronic infections)
- Lupus and related connective-tissue diseases, where CRP often stays relatively low during flares10
- Bone and joint infections in one hospital series10
Discordance is not an error to be ignored — it is information. Reviews emphasize that neither test is sensitive or specific enough to be read in isolation, and that the pattern, timing and clinical picture together tell the story.3
CRP and ESR in RA disease-activity scores (DAS28) Strong
In rheumatoid arthritis, treatment is guided by measuring disease activity regularly and adjusting therapy until remission or low activity is reached ("treat to target"). The best-known tool is the Disease Activity Score in 28 joints (DAS28), developed in 1995. It combines tender and swollen joint counts, your own global rating of how you are doing, and an inflammation marker.12 The American College of Rheumatology's 2019 update lists DAS28 with either ESR or CRP among its five preferred measures, alongside the CDAI, SDAI, RAPID3 and PAS-II.16
| Feature | DAS28-ESR | DAS28-CRP |
|---|---|---|
| Origin | The original, validated version12 | Later adaptation; validated against X-ray progression and function13 |
| Standard cut-offs | Remission < 2.6; low ≤ 3.2; high > 5.1 | Often the same cut-offs are used, but that is debated |
| Agreement | EULAR response category agreed in 82% of trial patients; when they disagreed, DAS28-CRP gave the better response more often (12.6% vs 4.9%)13 | |
| Proposed equivalent thresholds | 2.6 / 3.2 / 5.1 | About 2.3 / 2.7 / 4.1 in a Japanese cohort of 6,729 patients14; about 2.4 for remission across five trials15 |
| Influenced by | Age, sex, anemia, kidney function | Obesity (in women), IL-6–targeting drugs |
CRP and ESR also appear in the 2010 ACR/EULAR classification criteria for RA, where an abnormal CRP or ESR earns just 1 of the 10 possible points — a deliberate signal that these tests support, rather than drive, the diagnosis.17 See how RA is diagnosed.
Why normal results don't rule out arthritis Strong
This is the single most important practical point on this page. Many people with real, painful arthritis are told their "inflammation tests are fine" and assume nothing is wrong. The evidence shows why that reasoning fails:
| Condition | What CRP/ESR usually show | Evidence |
|---|---|---|
| Osteoarthritis | Usually normal or only slightly raised. A meta-analysis of 32 studies found hs-CRP only about 1.2 mg/L higher than in controls on average, linked to pain and function rather than X-ray severity.21 A clearly high CRP points away from OA alone. | Strong |
| Rheumatoid arthritis — at presentation | In 2,370 patients in Finland and the U.S., both ESR and CRP were normal in 33% and 42%; CRP alone was normal in 44% and 58%.18 | Strong |
| Rheumatoid arthritis — active disease | In 9,135 U.S. registry patients with clinically active RA, 58% had neither ESR nor CRP raised; only 16% had both raised.19 In knee biopsies, 49% of RA patients with a normal CRP still had inflamed synovium.20 | Strong |
| Gout | Often markedly raised during a flare, but commonly normal between attacks. Uric acid and joint-fluid crystal analysis matter more — see uric acid thresholds. | Strong |
You may see it said that around 40% of people with early RA have normal inflammation markers. The data above support the general idea, with a caveat about wording: at first presentation, roughly a third to over 40% had both ESR and CRP normal, depending on the cohort.18 Seronegative and "low-marker" RA is real and deserves the same attention as textbook cases. A 1986 review in Annals of Internal Medicine made the same point decades ago: ESR is often normal in infection, cancer and connective-tissue disease, so it cannot be used to exclude them.9
What else raises (or lowers) CRP and ESR
Both tests are non-specific: they say "something is going on," not what. A raised result needs to be put in context before it is pinned on the joints.34
| Factor | Effect | Evidence |
|---|---|---|
| Infection (viral, bacterial), recent surgery, injury | Raise both; CRP first and often higher with bacterial infection | Strong |
| Obesity and excess abdominal fat | Raise CRP. In 16,616 U.S. adults, obesity carried about 2× the odds of elevated CRP in men and about 6× in women, independent of smoking.22 In women with RA, higher BMI raised CRP independently of disease activity.24 | Strong |
| Smoking | Raises hs-CRP, fibrinogen and white cells in men, rising with pack-years; levels were lower the longer people had quit.23 | Strong |
| Chronic kidney disease | Raises ESR; linked to "high ESR, low CRP" discordance11 | Strong |
| Anemia, older age, female sex, pregnancy | Raise ESR345 | Strong |
| Other autoimmune disease, inflammatory bowel disease, some cancers, high immunoglobulins | Raise one or both | Strong |
| Poor sleep, sedentary lifestyle, insulin resistance | Associated with higher CRP; see biomarkers for sleep-restriction data | Emerging |
| Anti-inflammatory and immune treatments (steroids, NSAIDs, DMARDs, biologics) | Lower both as inflammation settles. IL-6–blocking drugs can suppress CRP so strongly that it no longer reliably signals infection — your care team will interpret results with this in mind. | Strong |
| Statins | Modestly lower CRP | Strong |
| Sickle cell disease, polycythemia, very high white cell counts | Can falsely lower ESR | Strong |
Low-grade inflammation and lifestyle: a balanced view Emerging
Holistic and functional-medicine practitioners often use hs-CRP as a general "inflammation barometer," aiming for values below 1 mg/L through diet, weight management, sleep and stress reduction. There is a reasonable basis for this: excess body fat, smoking and short sleep are consistently linked with higher CRP, and quitting smoking is associated with lower levels.2223 Our root causes and anti-inflammatory diet pages explore these drivers.
Mainstream rheumatology adds important caveats. Lowering hs-CRP is a marker change; it does not by itself prove that joint damage is prevented. In inflammatory arthritis such as RA, a normal CRP can coexist with active synovitis,20 and lifestyle measures have not been shown to replace disease-modifying treatment. The fairest summary is that healthy habits are worthwhile for everyone and may lower background inflammation, while diagnosed inflammatory arthritis still needs medical monitoring and treatment.
Questions to ask your doctor
Bringing these questions to your appointment can make a CRP or ESR result much more useful:
- Was this a standard CRP or an hs-CRP, and what units is it reported in?
- What is the reference range at this lab, and how does my result compare with my previous results?
- Could anything else explain it — a recent cold, infection, injury, dental problem, anemia, kidney function, pregnancy or weight?
- If CRP and ESR disagree, what do you think explains the difference?
- If my results are normal but my joints are swollen or stiff, what other tests or imaging would help (for example anti-CCP, RF, uric acid, ultrasound)?
- If I have RA, is my disease activity score DAS28-ESR, DAS28-CRP, CDAI or SDAI — and what is my target?
- Do any of my medicines affect these tests?
- When should the test be repeated?
Our guide to using biomarkers with your doctor has a broader checklist covering metabolic and autoimmune markers too.
When to see a doctor urgently Strong
- a hot, red, swollen joint with fever, chills or feeling generally unwell — septic arthritis can destroy a joint within days (see gout red flags);
- age over 50 with a new headache, scalp tenderness, jaw pain when chewing, or any change in vision — possible giant cell arteritis, which can cause permanent blindness and is typically associated with a high ESR and CRP;
- new shoulder and hip-girdle pain and stiffness over 50, especially with fatigue or weight loss — possible polymyalgia rheumatica;
- a very high result (for example CRP well above 100 mg/L or ESR above 100 mm/hr) with symptoms — this needs prompt investigation for infection, vasculitis or other serious causes;
- unexplained weight loss, night sweats or persistent fever with raised markers.
Book a routine appointment for joint pain with swelling or prolonged morning stiffness lasting more than a few weeks, even if earlier blood tests were normal. Early treatment of inflammatory arthritis protects joints — see the RA red flags.
Frequently asked questions
What is the difference between CRP and ESR?
CRP (C-reactive protein) is a protein the liver makes in response to the cytokine IL-6; it is measured directly and rises and falls within hours to days. ESR (erythrocyte sedimentation rate) is an indirect test that measures how fast red blood cells settle in a tube over one hour; it rises mainly because of fibrinogen and other proteins, changes more slowly over weeks, and is also affected by age, sex, anemia, pregnancy and kidney disease. This is educational information, not medical advice.
Which is better, CRP or ESR?
Neither is better for every purpose. CRP responds faster and is influenced by fewer non-inflammatory factors, so many clinicians prefer it for tracking acute inflammation and infection. ESR can stay raised longer and remains useful in some conditions, such as giant cell arteritis, polymyalgia rheumatica and certain bone infections. In rheumatoid arthritis both are validated for disease-activity scores, and checking both at the first visit is common.
What is a normal CRP and ESR?
Ranges vary by laboratory. Standard CRP is commonly reported as normal below about 5 to 10 mg/L (0.5 to 1.0 mg/dL). For hs-CRP used in heart-risk assessment, below 1 mg/L is low risk, 1 to 3 mg/L average and above 3 mg/L higher risk. A widely used rule of thumb for the upper limit of normal ESR is age divided by 2 for men and age plus 10, divided by 2, for women, in mm/hr.
Can you have arthritis with a normal CRP and ESR?
Yes. Osteoarthritis usually causes normal or only slightly raised results. In rheumatoid arthritis, studies have found both ESR and CRP normal at first presentation in about a third to over 40 percent of patients, and a large U.S. registry found 58 percent of people with clinically active RA had neither test raised. Gout is often normal between flares. A normal result never rules out arthritis on its own; diagnosis rests on history, examination, imaging and other tests.
What else can raise CRP or ESR besides arthritis?
Infections, injury, surgery, other autoimmune diseases, some cancers, obesity, smoking, poor sleep, pregnancy and chronic kidney disease can all raise one or both tests. ESR is also raised by anemia, older age and female sex. Because the tests are non-specific, a raised result is a clue to investigate with a clinician, not a diagnosis.
References
- Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111(12):1805–1812. PubMed 12813013
- Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340(6):448–454. PubMed 9971870
- Bray C, Bell LN, Liang H, et al. Erythrocyte sedimentation rate and C-reactive protein measurements and their relevance in clinical medicine. WMJ. 2016;115(6):317–321. PubMed 29094869
- Harrison M. Erythrocyte sedimentation rate and C-reactive protein. Aust Prescr. 2015;38(3):93–94. PubMed 26648629
- Miller A, Green M, Robinson D. Simple rule for calculating normal erythrocyte sedimentation rate. Br Med J (Clin Res Ed). 1983;286(6361):266. PubMed 6402065
- Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice. A statement for healthcare professionals from the CDC and the AHA. Circulation. 2003;107(3):499–511. PubMed 12551878
- Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003;107(3):363–369. PubMed 12551853
- Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease. Circulation. 2019;140(11):e596–e646. PubMed 30879355
- Sox HC Jr, Liang MH. The erythrocyte sedimentation rate: guidelines for rational use. Ann Intern Med. 1986;104(4):515–523. PubMed 3954279
- Feldman M, Aziz B, Kang GN, et al. C-reactive protein and erythrocyte sedimentation rate discordance: frequency and causes in adults. Transl Res. 2013;161(1):37–43. PubMed 22921838
- Costenbader KH, Chibnik LB, Schur PH. Discordance between erythrocyte sedimentation rate and C-reactive protein measurements: clinical significance. Clin Exp Rheumatol. 2007;25(5):746–749. PubMed 18078625
- Prevoo ML, van 't Hof MA, Kuper HH, et al. Modified disease activity scores that include twenty-eight-joint counts. Arthritis Rheum. 1995;38(1):44–48. PubMed 7818570
- Wells G, Becker JC, Teng J, et al. Validation of the 28-joint Disease Activity Score (DAS28) and EULAR response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate. Ann Rheum Dis. 2009;68(6):954–960. PubMed 18490431
- Inoue E, Yamanaka H, Hara M, et al. Comparison of Disease Activity Score (DAS)28-erythrocyte sedimentation rate and DAS28-C-reactive protein threshold values. Ann Rheum Dis. 2007;66(3):407–409. PubMed 16926186
- Fleischmann R, van der Heijde D, Koenig AS, et al. How much does Disease Activity Score in 28 joints ESR and CRP calculations underestimate disease activity compared with the Simplified Disease Activity Index? Ann Rheum Dis. 2015;74(6):1132–1137. PubMed 25143522
- England BR, Tiong BK, Bergman MJ, et al. 2019 update of the American College of Rheumatology recommended rheumatoid arthritis disease activity measures. Arthritis Care Res (Hoboken). 2019;71(12):1540–1555. PubMed 31709779
- Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569–2581. PubMed 20872595
- Sokka T, Pincus T. Erythrocyte sedimentation rate, C-reactive protein, or rheumatoid factor are normal at presentation in 35%–45% of patients with rheumatoid arthritis seen between 1980 and 2004: analyses from Finland and the United States. J Rheumatol. 2009;36(7):1387–1390. PubMed 19411389
- Kay J, Morgacheva O, Messing SP, et al. Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis. Arthritis Res Ther. 2014;16(1):R40. PubMed 24485007
- Orr CK, Najm A, Young F, et al. The utility and limitations of CRP, ESR and DAS28-CRP in appraising disease activity in rheumatoid arthritis. Front Med (Lausanne). 2018;5:185. PubMed 30123796
- Jin X, Beguerie JR, Zhang W, et al. Circulating C reactive protein in osteoarthritis: a systematic review and meta-analysis. Ann Rheum Dis. 2015;74(4):703–710. PubMed 24363360
- Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999;282(22):2131–2135. PubMed 10591334
- Fröhlich M, Sund M, Löwel H, et al. Independent association of various smoking characteristics with markers of systemic inflammation in men (MONICA Augsburg Survey 1994/95). Eur Heart J. 2003;24(14):1365–1372. PubMed 12871694
- George MD, Giles JT, Katz PP, et al. Impact of obesity and adiposity on inflammatory markers in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken). 2017;69(12):1789–1798. PubMed 28393498